Kamel M. Elberembally

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

King Khalid University(Current)

Kafrelsheikh University

Tanta University

Kamel M. Elberembally is an author at King Khalid University specializing in pharmacodynamics of anticancer agents, pyrimidine analogs, and pyrimidine chemistry.

Publications per year

2023–2024

Publications

Novel 4-(2-arylidenehydrazineyl)thienopyrimidine derivatives as anticancer EGFR inhibitors: Design, synthesis, biological evaluation, kinome selectivity and in silico insights

Heba A. Elsebaie, Eman A. El-Bastawissy, Kamel M. Elberembally et al. · Bioorganic Chemistry · 2023 · 39 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17

Development of new thieno[2,3-d]pyrimidines as dual EGFR and STAT3 inhibitors endowed with anticancer and pro-apoptotic activities

Heba A. Elsebaie, Tarek F. El‐Moselhy, Eman A. El-Bastawissy et al. · Bioorganic Chemistry · 2024 · 34 citations

Pharmacy, Medicinal Chemistry, Oncology +14

1–2 of 2